Soaring costs of cardiovascular disease in the US

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.621, 2011-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is pharma to blame for soaring US healthcare costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 396, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Costs of inflammatory bowel disease in the US substantial

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cost Estimation of Cardiovascular Disease Events in the US

By O'Sullivan Amy K.

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 693-704

Adis International

Access to resources Recommend Favorite

Drug Costs Associated with Non-Adherence to Cholesterol Management Guidelines for Primary Prevention of Cardiovascular Disease in an Elderly Population: The Rotterdam Study

By Gumbs Pearl D.

Drugs & Aging, Vol. 23, Iss. 9, 2006-01 ,pp. : 733-741

Adis International

Access to resources Recommend Favorite

Depression increases cardiovascular healthcare costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite